original ) (raw )Comparison of the Generic HIV Viral Load® assay with the Amplicor™ HIV-1 Monitor v1.5 and Nuclisens HIV-1 EasyQ® v1.2 techniques for plasma HIV-1 RNA quantitation of non-B subtypes: The Kesho Bora preparatory study
Francois Rouet
Journal of Virological Methods, 2010
View PDFchevron_right
Human Immunodeficiency Virus Type 1 (HIV-1) Plasma Load Discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 Assays
Ebi Celestin Bile
Journal of Clinical Microbiology, 2007
View PDFchevron_right
Evaluation of the Abbott m2000 RealTime Human Immunodeficiency Virus Type 1 (HIV1) Assay for HIV Load Monitoring in South Africa Compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV1, and BioMerieux NucliSENS EasyQ HIV1 Assays
Wendy Stevens
2009
View PDFchevron_right
Comparative Evaluation of the Performance of the Abbott Real-Time Human Immunodeficiency Virus Type 1 (HIV-1) Assay for Measurement of HIV-1 Plasma Viral Load following Automated Specimen Preparation
Dimitrios Paraskevis
Journal of Clinical Microbiology, 2006
View PDFchevron_right
Lack of correlation between three commercial platforms for the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of quantification
Leon McNally
Journal of Clinical Virology, 2010
View PDFchevron_right
Evaluation of the Abbott m2000rt RealTime™ HIV-1 assay with manual sample preparation compared with the ROCHE COBAS® AmpliPrep™/AMPLICOR™ HIV-1 MONITOR® v1.5 using specimens from East Africa
John Crump
Journal of Virological Methods, 2009
View PDFchevron_right
Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes
Victoria Polonis
Journal of clinical microbiology, 1999
View PDFchevron_right
Quantitation of HIV1 RNA Viral Load Using NASBA Methodology and Comparison with other Surrogate Markers for Disease Progression
João Renato Rebello Pinho
Memorias Do Instituto Oswaldo Cruz, 1998
View PDFchevron_right
A Rapid and Automated Sample‐to‐Result HIV Load Test for Near‐Patient Application
Shuqi Chen
The Journal of Infectious Diseases, 2010
View PDFchevron_right
Evaluation of the RealTime HIV-1, Xpert HIV-1, and Aptima HIV-1 Quant Dx Assays in Comparison to the NucliSens EasyQ HIV-1 v2.0 Assay for Quantification of HIV-1 Viral Load
Orna Mor
Journal of Clinical Microbiology, 2015
View PDFchevron_right
Evaluation of Quantification of HIV-1 RNA Viral Load in Plasma and Dried Blood Spots by Use of the Semiautomated Cobas Amplicor Assay and the Fully Automated Cobas Ampliprep/TaqMan Assay, Version 2.0, in Kisumu, Kenya
John Williamson
Journal of Clinical Microbiology, 2013
View PDFchevron_right
Use of an HIV-1 reverse-transcriptase enzyme-activity assay to measure HIV-1 viral load as a potential alternative to nucleic acid-based assay for monitoring antiretroviral therapy in resource-limited settings
vidya madhavan
Journal of Medical Microbiology, 2007
View PDFchevron_right
Evaluation of two commercially available alternatives for HIV-1 viral load testing in resource-limited settings
Jean Plum
Journal of Virological Methods, 2007
View PDFchevron_right
Comparative Performances of HIV-1 RNA Load Assays at Low Viral Load Levels: Results of an International Collaboration
Alessandra Amendola
Journal of Clinical Microbiology, 2014
View PDFchevron_right
Comparison of 3 Tests for Plasma HIV-1 RNA Quantitation of Non-B Subtypes in Patients Infected with HIV-1 in N’Djamena-Chad: Cobas AmpliPrep/Cobas TaqMan HIV-1 Test Version 2.0, Abbott m2000 RealTime and Generic HIV Viral Load® Assays
Erick Kamangu
Journal of Infectious Diseases & Therapy, 2018
View PDFchevron_right
Comparison of the Aptima HIV-1 Quant Dx assay with the COBAS AmpliPrep/COBAS TaqMan HIV-1 v2.0 Test for HIV-1 viral load quantification in plasma samples from HIV-1-infected patients
Isabella Bon
Health science reports, 2018
View PDFchevron_right
Impact of Human Immunodeficiency Virus Type 1 (HIV-1) Genetic Diversity on Performance of Four Commercial Viral Load Assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT
Carmen de Mendoza
Journal of Clinical Microbiology, 2005
View PDFchevron_right
Performance characteristics of the Cavidi ExaVir viral load assay and the ultra-sensitive P24 assay relative to the Roche Monitor HIV-1 RNA assay
Charles van der Horst
Journal of Clinical Virology, 2010
View PDFchevron_right
Clinical Evaluation of a Low Cost, In-House Developed Real-Time RT-PCR Human Immunodeficiency Virus Type 1 (HIV-1) Quantitation Assay for HIV-1 Infected Patients
wei xin Khong
PLoS ONE, 2014
View PDFchevron_right
Comparison of Two Human Immunodeficiency Virus (HIV) RNA Surrogate Assays to the Standard HIV RNA Assay
Donald Brambilla
2005
View PDFchevron_right
Performance Comparison of Xpert HIV-1 Viral Load Assay and Roche Taqman and Abbott M2000 RT in Bamako, Mali
BOCAR BAYA
Journal of AIDS & clinical research, 2020
View PDFchevron_right
Clinical performance of an in-house real-time RT-PCR assay using a fluorogenic LUX™ primer for quantitation of human immunodeficiency virus type-1 (HIV-1)
Robin Wood
Journal of Virological Methods, 2007
View PDFchevron_right
High correlation between the Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypes
J. Karasi
Journal of Clinical Virology, 2011
View PDFchevron_right
Establishment of In-House Quantitative Real-Time RT-PCR Assay for HIV-1 Viral Load Measurement: Application to Evaluate Efficacy of ART in Ghanaian Patients in an Urban Setting
Kofi Bonney
Journal of AIDS & Clinical Research, 2014
View PDFchevron_right